Advanced heart failure and pulmonary hypertension significantly compromise patients' quality of life. This has led to the development of technologies such as the CardioMEMS device for their management. Although its use is widely approved for adults with advanced heart failure [1], its application in pediatrics [2], especially outside conventional heart failure scenarios [3,4], is innovative and considered compassionate due to the lack of approval by regulatory entities such as the FDA and CE marking for this age group. On the other hand, cardiac catheterizations in pediatric patients, especially diagnostic procedures to assess pulmonary pressures, are not without risks [5].
No takes yet. Share an insight, caveat, or question.
Aguado et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: